A Dignity Health study indicates that the use of digital health technology is an effective way to improve asthma control.
Dignity Health, a national leader in healthcare systems, recently announced the results of a randomized, controlled study, indicating the use of digital health technology — namely the Propeller Health Asthma Platform — as an effective strategy to improve asthma control.
The Propeller Health Asthma Platform uses sensors, mobile apps, and analytics for the comprehensive monitoring of short-acting ?-agonist (SABA) and inhaled corticosteroids use in real-time. Additionally, the platform delivers in-depth information about the medications’ patterns of use, and notifies caregivers about patients who are struggling with controlling their asthma.
“We are very pleased with the growing body of data that supports the effectiveness of our asthma platform,” said Propeller Health CEO David Van Sickle. “Our partnership with Dignity Health is important as we continue to advance innovation in chronic respiratory disease management and improve patients’ quality of life.”
The study, “Effectiveness of Population Health Management Using the Propeller Health Asthma Platform: A Randomized Clinical Trial,” was published in the The Journal of Allergy and Clinical Immunology: In Practice.